Four and a half LIM domain protein 2 (FHL2) is a LIM domain 22 protein expressed in muscle tissue whose deletion is causative of 23 myopathies. Although FHL2 has a confirmed important role in muscle 24 development, its autophagy-related function in muscle differentiation has 25 not been fully determined. To explore the role of FHL2 in 26 autophagy-related muscle regulation, FHL2-silenced and -overexpressing 27 C2C12 mouse cells were examined. Immunofluorescence and 28 co-immunoprecipitation assay findings showed that FHL2 silencing 29 reduced LC3-Ⅱ protein expression and the amount of LC3 that 30 co-immunoprecipitated with FHL2, indicating that FHL2 interacts with 31 LC3-Ⅱ in the formation of autophagosomes. Moreover, the expression of 32 muscle development marker genes such as MyoD1 and MyoG was lower 33 in FHL2-silenced C2C12 cells but not in FHL2-overexpressing C2C12 34 cells. Electron microscopy analysis revealed large empty autophagosomes 35 in FHL2-silenced myoblasts, while flow cytometry suggested that FHL2 36 silencing made cells more vulnerable to staurosporine-induced cell death.
Introduction 42
Four and a half Lim domain protein 2 (FHL2) belongs to the FHL 43 protein family which contains five members: FHL1, FHL2, FHL3, FHL4, 44 and ACT [1] . Despite their high level of conservation among species, 45 their expression levels differ from each other between tissues. FHL1, 46 FHL2, and FHL3 are mainly expressed in skeletal and heart muscle [2] , 47 whereas FHL4 and ACT are highly expressed in the testis [3] . FHL2 has 48 been shown to have a dual function in interacting with the cytoplasmic 49 domain of several integrin chains [4] , and also as a transcriptional 50 coactivator of the androgen receptor [5] . Although FHL2 plays an 51 important role in muscle development and its deletion was reported to 52 lead to the development of myopathies [2, [6] [7] [8] [9] [10] , the details of its 53 function in skeletal muscle development are unclear. 54 Autophagy is the major intracellular degradation system by which 55 cytoplasmic materials are delivered to and degraded in the lysosome, 56 which also serves as a dynamic recycling system that produces new 57 building blocks and energy for cellular renovation and homeostasis [11, 58 12] . Recently, the relationship between autophagy and muscle cell 59 development has been shown to play an important role in muscle mass 60 maintenance and integrity [13, 14] . As the main proteolytic system that 61 controls protein degradation in skeletal muscle cells, the autophagy 62 lysosome is activated in a number of catabolic disease states that lead to 63 Table 1 .
115
Western blot assay 116 The cells were collected from the cultures, placed in the RIPA lysis 117 buffer on ice (BestBio, Shanghai, China). The whole proteins were 118 subjected to 10% sodium dodecyl sulfate polyacrylamide gel 119 electrophoresis (SDS-PAGE) and then transferred to polyvinylidene 120 fluoride membranes (PVDF; Millipore Corporation, Billerica, MA, USA).
121
The PVDF membrane was incubated with 5% defatted milk powder at 122 room temperature for 1 h, then incubation with the following specific 
132
Quantification of protein blots was performed using the Quantity One three times in the sodium cacodylate buffer and incubated in 2% osmium 148 tetroxide in the same buffer for 2 h at room temperature. Afterwards, the 149 cells were rinsed three times in distilled water and exposed to 1% uranyl 150 acetate in water for 15 min at room temperature and twice in distilled FHL2-silenced cells compared with control cells (Fig. 1B) . Next, 216 morphological differences between negative control and FHL2 217 11 siRNA-transfected groups were compared during C2C12 differentiation 218 into myotubes. The FHL2-silenced group showed reduced myotube 219 formation (Fig. 1C) , and the expression of myogenic marker genes 220 MyoD1, MYH3, and MyoG was significantly reduced in FHL2-silenced 221 cells compared with controls ( Fig. 1D-F) . Moreover, western blotting 222 revealed that MYH3 and MyoG protein levels were reduced after FHL2 223 silencing (Fig. 1G) . These results suggest that FHL2 siRNA was effective 224 and that FHL2 plays an important role in muscle differentiation by 225 regulating myogenesis-related genes. The overexpression of FHL2 in 226 C2C12 myoblasts and myotubes ( Fig. 2A and B) had no significant effect 227 on MyoG, MyoD1, or MYH3 expression levels ( Fig. 2C-E) . to be reduced in FHL2-silenced myoblasts and myotubes compared with 236 controls (Fig. 3B) . Interestingly, the starvation of FHL2-silenced 237 myoblasts and myotubes, which should have been able to activate 238 autophagy, did not induce the accumulation of LC3-Ⅱ (Fig. 3B ). 239 12 Moreover, FHL2 overexpression did not significantly influence the 240 expression of ATG5 or ATG7 (Fig. 3C ).
241
To further confirm our findings, we used TEM to observe the 242 ultrastructure of myoblasts. As shown in Fig. 4 , both negative control and 243 FHL2-overexpressing myoblasts were observed to contain normal 244 autophagosomes whereas large empty autophagosomes were present in 245 FHL2-silenced myoblasts, which was indicative of impaired autophagy.
246

FHL2-LC3-Ⅱ co-localization 247
Immunofluorescence and co-immunoprecipitation assays were next 248 performed to determine whether FHL2 co-localized with the 249 autophagosomal marker LC3 during myoblast differentiation.
250
Immunofluorescence analysis showed similar FHL2 and LC3 protein 251 distribution in myoblasts (Fig. 5A ), while FHL2 silencing decreased both 252 FHL2 and LC3Ⅱ expression which was indicative of their co-expression 253 (Fig. 5A) . The co-immunoprecipitation assay revealed co-localization of 254 FHL2 and LC3 proteins in C2C12 cells during myoblast differentiation, 255 and reduced co-immunoprecipitation in FHL2-silenced myoblasts 256 compared with control cells (Fig. 5B) . These results support a role for 257 FHL2 in the formation of autophagosomes by binding LC3 in an 258 intracellular complex. 260 Flow cytometry was next used to measure cell death after treatment 261 13 of C2C12 cells with 2 μM STS for 12 h. Cell death was observed in 2.74% 262 and 3.51% of wild-type (WT) myoblasts and myotubes, respectively, 263 compared with 6.30% and 10.77%, respectively, in si-FHL2 groups (Fig.   264 6B and D). This indicated that FHL2 silencing enhanced apoptosis in 265 both myoblasts and myotubes. Moreover, a decreased resistance to STS 266 was detected in FHL2-silenced myoblasts and myotubes ( Fig. 6A-D) .
259
FHL2 silencing promoted apoptosis in both myoblasts and myotubes
267
Western blotting of PARP and caspase-3 proteins under different 268 conditions revealed the increased accumulation of PARP in myoblasts 269 following FHL2 silencing (Fig. 6E ). Caspase-3 protein expression was 270 not detected in WT cells, but was observed in si-FHL2 myotubes, 271 suggesting an important role for FHL2 in protecting myotubes from 272 apoptosis (Fig. 6E ). We also found that myotubes were more resistant to 273 STS-induced apoptosis than myoblasts (Fig. 6E ).
274
Discussion
275
Although previous studies suggested that FHL2 is involved with 276 autophagy and may be associated with LC3 protein [19, 23] , its 277 autophagy-related role in muscle differentiation had not been fully 278 determined. In this study, we explored the mechanism of FHL2 in muscle 279 differentiation through autophagy induction. 280 We initially confirmed that FHL2 played a role in muscle 
288
Those results confirm that FHL2 play a part in muscle development.
289
Previous studies detected LC3 protein accumulation during muscle 290 cell development by western blotting [24, 25] . We investigated the 291 relationship between FHL2 and autophagy using two methods: first, 292 measuring the expression of genes essential for autophagy such as ATG5 293 and ATG7 [26] following FHL2 knockdown, and second, measuring the 294 correlation between FHL2 and LC3Ⅱ. Knockdown, but not the 295 overexpression, of FHL2 significantly decreased the expression of ATG5 296 and ATG7 in both myoblasts and myotubes. Additionally, the autophagy 297 level as indicated by the ratio of LC3-Ⅱ to LC3-I protein [27] was 298 reduced in FHL2-silenced myoblasts and myotubes. These results 299 indicate a role for FHL2 in autophagy induction.
300
It is reasonable to assume that the function of FHL2 in muscle 301 development is associated with autophagy because similar effects on 302 muscle-related genes and autophagy markers were detected following 303 FHL2 silencing or overexpression. Moreover, the starvation that activated 304 autophagy in control cells did not induce LC3-Ⅱ accumulation in either weakness, and autophagy is required to maintain muscle mass [17, 28] . 311 Therefore, our results suggest that FHL2 has a role in myotube formation 312 by activating cell autophagy to maintain cellular homeostasis.
313
MLP/CSRP3 containing a LIM domain has been reported to 314 participate in muscle differentiation and autophagosome formation by 315 interacting with LC3-Ⅱ [20] . FHL2 also contains four and a half LIM 316 domains that act as a protein-protein binding interface involved in muscle 317 differentiation [29] . Considering the potential of FHL2 to bind LC3-Ⅱ, its 318 correlation with LC3-Ⅱ at the protein level in C2C12 cells, and its likely 319 role in the assembly of extracellular membranes [30] , we hypothesized 320 that FHL2 participates in autophagosome formation by interacting with 321 LC3-Ⅱ. We therefore next explored their localization in C2C12 cells. The autophagy can also protect cells from apoptosis [31] . Study has revealed 331 autophagy protects myoblasts against apoptosis [32] . In a previous study, 332 the specific autophagy inhibitor 3MA [33] was used to treat C2C12 cells, 333 resulting in increased CASP3 activity which is a marker of increased 334 apoptosis [18] . If FHL2 functions in the induction of autophagy, 335 FHL2-silenced C2C12 cells would be expected to show more apoptosis. 
